Cointime update: Hengrui Medicine said 12 of its products were included in the latest adjustment of China’s national medical insurance drug list, with three new drugs entering the reimbursement scheme for the first time. Two innovative drugs had new indications added to the list, while seven products completed renewals of their existing listings. The company said the changes improve access to quality medicines and ease patients’ drug costs.
Hengrui Medicine’s 12 Products Adjusted in New National Medical Insurance List; 3 New Drugs Entered for First Time
Share on WeChat
Open WeChat → Scan → then tap "…" to send to a chat or Moments.
Tap "…" in the top-right corner to send to a chat or share to Moments.
Related News
10m ago
UBS Global Wealth Management Forecasts S&P 500 at 8,200 by End-2027
32m ago
Tencent Q3 2026 Revenue Rises 8% to RMB 207.3 Billion
35m ago
Onshore yuan closes at 6.6653 per dollar, up 2 pips
52m ago
Hong Kong’s Hang Seng closes down 0.91%; Zhipu jumps over 9%
1h ago
Goldman Sachs Forecasts Gold May Return to $5,600 by Late 2028
2h ago
Dollar Holds Near 19-Month High on Fed Rate Hike Expectations